-
Stimulus bill packs a windfall for FDA and COVID-19 drug developers — Roche nixes Tecentriq bladder cancer accelerated approval — AI uncovers Lilly's Olumiant as potential Alzheimer's treatment See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Matrix management (doesn't work at B+L)
Discussion in 'Bausch & Lomb' started by Anonymous, Aug 11, 2011 at 5:44 AM.
Tags:
Add Tags